U.S. Healthcare Large Cap High Growth Potential

Guardant Health

Market Cap: US$21.6b

A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

Glaukos

Market Cap: US$10.9b

An ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.

BrightSpring Health Services

Market Cap: US$13.0b

Operates as a home and community-based healthcare services platform in the United States.

Baxter International

Market Cap: US$12.9b

Through its subsidiaries, provides a portfolio of healthcare products in the United States.

Edwards Lifesciences

Market Cap: US$50.0b

Provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.

Cooper Companies

Market Cap: US$13.2b

Develops, manufactures, and markets contact lens wearers.

Medline

Market Cap: US$45.6b

Manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.

Humana

Market Cap: US$48.4b

Provides medical and specialty insurance products in the United States.

Becton Dickinson

Market Cap: US$48.8b

Develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide.

Centene

Market Cap: US$31.9b

Operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.

Molina Healthcare

Market Cap: US$10.2b

Provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.